Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
49
FCNCA Quote, Financials, Valuation and Earnings
Last price:
$2,113.65
Seasonality move
:
2.43%
Day range:
$2,033.65 - $2,130.82
52-week range:
$1,363.97 - $2,388.78
Dividend yield:
0.32%
P/E ratio:
12.21x
P/S ratio:
3.24x
P/B ratio:
1.36x
Volume:
141.8K
Avg. volume:
92.2K
1-year change:
51.21%
Market cap:
$29.8B
Revenue:
$8.8B
EPS (TTM):
$174.55
Earnings Data
Next earnings date for FCNCA
Jan 24
2025
Most recent earnings per share
$43.42
Missed by $3.90
(Oct 24/2024)
Consensus Estimate
$47.32
(Oct 24/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
FCNCA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/24/2025 | Q4 | $2.2B | -- | -- | $39.30 | -- |
| 10/24/2024 | Q3 | $2.3B | $2.4B | $43.42 | $47.32 | -$3.90 |
| 07/25/2024 | Q2 | $2.3B | $2.4B | $47.54 | $45.00 | $2.54 |
| 04/25/2024 | Q1 | $2.4B | $2.4B | $49.26 | $44.15 | $5.11 |
| 01/26/2024 | Q4 | $2.4B | $2.3B | $34.33 | $49.34 | -$15.01 |
| 10/26/2023 | Q3 | -- | -- | $50.67 | $48.83 | $1.84 |
| 08/03/2023 | Q2 | -- | -- | $45.87 | $48.15 | -$2.28 |
| 05/10/2023 | Q1 | -- | -- | $653.64 | $12.51 | $641.13 |
| 01/26/2023 | Q4 | -- | -- | $16.70 | $22.98 | -$6.28 |
| 10/27/2022 | Q3 | -- | -- | $19.25 | $19.65 | -$0.40 |
| 07/28/2022 | Q2 | -- | -- | $14.86 | $17.02 | -$2.16 |
| 04/28/2022 | Q1 | -- | -- | $16.70 | $8.53 | $8.17 |
| 01/26/2022 | Q4 | -- | -- | $12.09 | $10.95 | $1.14 |
| 10/27/2021 | Q3 | -- | -- | $12.17 | $11.21 | $0.96 |
| 08/03/2021 | Q2 | -- | -- | $15.09 | $11.98 | $3.12 |
| 04/28/2021 | Q1 | -- | -- | $14.53 | $11.94 | $2.60 |
| 01/26/2021 | Q4 | -- | -- | $13.59 | -- | -- |
| 10/27/2020 | Q3 | -- | -- | $14.03 | -- | -- |
| 07/28/2020 | Q2 | -- | -- | $14.74 | -- | -- |
| 04/28/2020 | Q1 | -- | -- | $5.46 | -- | -- |
| 01/28/2020 | Q4 | -- | -- | $9.55 | -- | -- |
| 10/29/2019 | Q3 | -- | -- | $11.27 | -- | -- |
| 07/30/2019 | Q2 | -- | -- | $10.56 | -- | -- |
| 04/30/2019 | Q1 | -- | -- | $9.67 | -- | -- |
| 01/30/2019 | Q4 | -- | -- | $7.62 | -- | -- |
| 10/24/2018 | Q3 | -- | -- | $9.80 | -- | -- |
| 07/26/2018 | Q2 | -- | -- | $7.77 | -- | -- |
| 04/25/2018 | Q1 | -- | -- | $8.35 | -- | -- |
| 01/31/2018 | Q4 | -- | -- | $4.53 | -- | -- |
| 10/25/2017 | Q3 | -- | -- | $5.58 | -- | -- |
| 07/26/2017 | Q2 | -- | -- | $11.21 | -- | -- |
| 04/26/2017 | Q1 | -- | -- | $5.63 | -- | -- |
| 01/25/2017 | Q4 | -- | -- | $4.39 | -- | -- |
| 10/26/2016 | Q3 | -- | -- | $4.28 | -- | -- |
| 07/27/2016 | Q2 | -- | -- | $5.77 | -- | -- |
| 04/27/2016 | Q1 | -- | -- | $4.34 | -- | -- |
| 01/27/2016 | Q4 | -- | -- | $3.56 | -- | -- |
| 10/28/2015 | Q3 | -- | -- | $4.66 | -- | -- |
| 07/29/2015 | Q2 | -- | -- | $3.71 | -- | -- |
| 05/07/2015 | Q1 | -- | -- | $5.59 | $2.65 | $2.94 |
| 02/25/2015 | Q4 | -- | -- | $5.24 | $2.74 | $2.51 |
First Citizens BancShares Earnings Questions
-
How Much did First Citizens BancShares Generate in Revenue Last Quarter?
First Citizens BancShares reported $2.4B worth of top line sales in its most recent quarter.
-
Did First Citizens BancShares Beat Earnings Last Quarter?
First Citizens BancShares announced earnings per share of $43.42 which represents a miss of analyst forecast a $47.32 per share.
-
Is First Citizens BancShares Profitable?
First Citizens BancShares reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for First Citizens BancShares EPS Next Year?
First Citizens BancShares's earnings are forecast to decrease from $784.51 per share to $177.11 per share next year representing a decrease of -76.12%.
-
When is First Citizens BancShares's Earnings Date?
First Citizens BancShares's next earnings date is January 24, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is down 0.92% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 7.95% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.91% over the past day.
